May 9, 2018 / 11:15 AM / 17 days ago

BRIEF-Horizon Pharma Q1 Non-Gaap Earnings Per Share $0.03

May 9 (Reuters) - Horizon Pharma PLC:

* REPORTS STRONG FIRST-QUARTER 2018 ORPHAN AND RHEUMATOLOGY NET SALES GROWTH; INCREASES FULL-YEAR 2018 GUIDANCE AND ANNOUNCES NEW COMPANY OPERATING STRUCTURE TO ENHANCE FOCUS ON RARE DISEASES

* SEES FY 2018 SALES $1.17 BILLION TO $1.2 BILLION

* Q1 NON-GAAP EARNINGS PER SHARE $0.03

* Q1 GAAP LOSS PER SHARE $0.96

* Q1 SALES $223.9 MILLION VERSUS I/B/E/S VIEW $233.1 MILLION

* Q1 EARNINGS PER SHARE VIEW $0.06 — THOMSON REUTERS I/B/E/S

* SEES 2018 ADJUSTED EBITDA GUIDANCE RANGE TO $390 MILLION TO $415 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below